Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

St. James's Place flags strong start to 2025

(Sharecast News) - St. James's Place reported a strong start to 2025 on Thursday, with gross inflows rising to £5.14bn in the first quarter, up from £3.97bn a year earlier. The FTSE 100 firm said net inflows more than doubled to £1.69bn, compared to £0.71bn in the same period last year, reflecting improved client engagement and retention.

Its annualised net inflow rate as a percentage of opening funds under management increased to 3.6%, while the retention rate edged higher to 95.0%.

Total funds under management reached £188.59bn at the end of March, up from £179.04bn a year earlier.

"I am pleased to report another strong quarter for new business, once again demonstrating the strength of our advice-led business model and the trusted relationships our advisers build with clients," said chief executive officer Mark FitzPatrick.

"The external environment has been uncertain, but our advisers have reassured clients and helped them remain focused on their long-term financial goals and aspirations.

"Engagement levels have been high, and this has resulted in £5.1bn of new client investments during the quarter."

FitzPatrick said retention of funds under management remained strong at 95%, supporting net inflows of £1.7bn.

"A decline in global markets during the quarter impacted our funds under management, which closed the period at £188.6 billion.

"We are pleased to have built momentum in new business in recent quarters, and we have continued to see good levels of client engagement and activity so far in April.

"Looking forward, macroeconomic uncertainty and market volatility create a challenging environment for savers and investors, but one which underlines the value that trusted financial advice delivers to clients."

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.